Federal awards

Alto, Neal, NIH, Bacterial Regulation of Eukaryotic Signaling Enzymes: Structure and Function, $30,210; Amatruda, James, Children’s Hosp of Phila/NIH, NIH National Clinical Trials Network (NCTN) Grant (U10CA180886), $13,721; Brekken, Rolf (Fellow K. Aguilera), NIH, SPARC as Regulator of Collagen Signaling in Pancreatic Cancer - Diversity Fellowship, $444; Brown, Sherwood, NIH, Attenuation of Corticosteroid-Induced Hippocampal Changes, $273,679; Browning, Jeffrey, NIH, Role of Mitochondrial Dysfunction in Non-Alcoholic Fatty Liver Disease, $366,541; Carroll, Thomas, NIH, Interactions Between Stroma and Progenitor Cells During Kidney Development, $34,582;

Casey, Brian, George Washington Univ/NIH, MEFU NICHD Network - Capitation Payments, $111,705; Chen, Zhijian, NIH, Biochemical Dissection of RIG-I Antiviral Pathway, $397,500; Chook, Yuh Min, NIH, Structures and Mechanisms of Nuclear Import and Export, $333,488; Cobb, Melanie (Fellow M. Kalwat), NIH, Role of Isoxazole Compounds in Beta Cell Differentiation and Function, $912; Corey, David, NIH, Allele-Selective Inhibitors for Expanded Trinucleotide Repeat Genes, $325,553; Corey, David, NIH, Mechanism of RNA-Mediated Control of Transcription of Splicing, $286,200;

Elmquist, Joel, NIH, Leptin Action and Central Melanocortin Systems, $354,583; Ge, Wuping, NIH, Local Proliferation of Glia and Their Interaction with Blood Vessels, $244,416; Greene, Robert, NIH, Glial Control of CNS State-Related Activity, $347,813; Hall, Christiana, Univ of Cincinnati/NIH, Ethnic/Racial Variation in Intracerebral Hemorrhage (ERICH), $34,802; Hansen, Eric, NIH, Haemophilus Ducreyi Inhibits Phagocytosis, $397,500; Herz, Joachim, NIH, Metabolism of the VLDL Receptor and ApoE Receptor, $399,713;

Hobbs, Helen, NIH, Role of ABCG5 and ABCG8 in Sterol Metabolism, $461,426; Jiang, Steve, NIH, Low Dose Cone Beam CT for Image Guided Adaptive Radiotherapy, $291,668; Johnson, Mark, Univ of Miami/NIH, Mechanisms of Early Recurrence in Intracranial Atherosclerotic Disease (MyRIAD), $10,104; Johnson, Mark, Yale Univ/NIH, Insulin Resistance Intervention after Stroke (IRIS) Trial, $886; Kavalali, Ege (Fellow D. Crawford), NIH, Role of Spontaneous Neurotransmission in Synaptic Plasticity and Behavior, $912; Kennard, Beth, NIH, 2/2 Brief Intervention for Suicide Risk Reduction in High Risk Adolescents, $19,875;

Kohler, Jennifer, NIH, Study of Sialoside Function Using Photocrosslinking Sialic Acid, $36,570; Kraus, William, Univ of Rochester/NIH, Environmental Influences on Epigenetic Immune Programming, $21,056; Leavey, Patrick, Children’s Hosp of Phila/NIH, National Clinical Trials Network (NCTN) Per Case Reimbursement, $41,000; Luo, Weibo, NIH, The Role of JMJD2C in HIF-1 Activation and Breast Cancer Progression, $24,900; Morrison, Sean, NIH, Regulation of Protein Synthesis in Stem Cells, $276,660; Niederkorn, Jerry, NIH, Immunobiology of Corneal Allografts, $31,800;

Norgard, Michael, NIH, Structure and Function of Treponema Pallidum Lipoproteins, $617,627; North, Carol, Univ of Southern Calif/NIH, Predictors of Major Depressive Disorder in Disaster Survivors, $14,355; Parada, Luis, NIH, Genetic Mouse Models of Glioma, $393,340; Rodriguez-Baez, Norberto, Univ of Pittsburgh/NIH, Acute Liver Failure in Children, $120,073; Rodriguez-Baez, Norberto, Univ of Pittsburgh/NIH, Acute Liver Failure in Children – Per Patient, $24,000;

Rosenbaum, Daniel, NIH, Molecular Mechanism of a Master Regulator of Sterol Homeostasis, $310,888; Ross, Elliott, NIH, G Protein-Coupled Receptors – Structure and Regulation, $39,750; Rutherford, Cynthia, UTHSC Houston/HRSA, Subaward Hemophilia Treatment Center (SPRANS), $23,277; Scaglioni, Pier, Dept of Defense, Deconstruction of Oncogenic K-RAS Signaling Reveals Focal Adhesion Kinase as Novel Therapeutic Target in NSCLC, $278,250; Shang, Ty, UTHSC Houston/NIH, Intravenous Thrombolysis Plus Hypothermia for Acute Treatment of Ischemic Stroke - 2/3 (ICTuS-2/3), $22,500; Shetgiri, Rashmi, NIH, Community-Based Prevention of Youth Violence in Latinos, $14,937;

Shiloh, Michael, NIH, Identification of Novel M. Tuberculosis Secreted Effector Proteins, $235,092; Skapek, Stephen, Children’s Hosp of Phila/NIH, Skapek – COG STS Biology Vice Chair, $14,048; Sternweis, Paul, NIH, Signal Transduction Via Receptors and G Proteins, $492,142; Story, Michael, WYLE/NASA, Omics Analysis, $25,760; Story, Michael, UT MD Anderson/NIH, Markers and Therapeutic Strategies for Overcoming Chemoradiotherapy Resistance, $14,008; Stowe, Ann, NIH, B Cells Alter Adaptive Autoimmunity to Protect from Ischemic Injury After Stroke, $353,281;

Vongpatanasin, Wanpen, NIH, Role of Aldosterone on Augmented Exercise Pressor Reflex in Hypertension, $542,731; Wang, Jing, NIH, Next Generation 4D-CBCT for Lung Cancer Radiation Therapy, $347,047; Wang, Yingfei, NIH, The Role of a Novel AIF-Associated Nuclease PAAN1 in Neuronal Injury, $249,001; Wu, Jiang, NIH, Role of Autism-Associated Chromatin Remodeler Brg1 in Neuronal Development, $19,875; Yan, Nan, NIH, HIV Subversion of Innate Immunity, $397,500; Yan, Nan, NIH, HIV Subversion of Innate Immunity – Diversity Supplement, $68,665; Yu, Gang, NIH, Gamma-Secretase and Myelin: A Paradigm Shift in Brain Disorders, $34,782; Zhang, Chengcheng, NIH, Role of Inhibitory Receptors in Leukemia Development, $329,925.

Nonfederal awards

Amatruda, James, Alex’s Lemonade Stand, B-lapachone as a Novel Targeted Therapy for ATRTs and Other Pediatric Cancers, $125,000; Camp, Mary, George Washington Univ, GWish-Templeton Reflection Rounds, $25,000; Greenberg, Benjamin, Guthy-Jackson Charitable Fdn, NMO Repository Traveling Nurse, $119,900; Gupta, Rana, American Heart Assoc SW, Investigating the Role of Adipocyte Hyperplasia in the Development of Lipotoxicity, $70,000; Hill, Joseph (Fellow Z. Wang), American Heart Assoc Natl, Xbp1s Protects Heart from Ischemia/Reperfusion Injury Through Activation of the Hexosamine Biosynthetic Pathway, $77,000; Hodics, Timea, American Heart Assoc SW, dTDCS-Enhanced Therapy after Hemorrhagic Strokes and VEGF, $70,000;

Hsieh, Jer-Tsong, UT Dallas/CPRIT, Mapping Acidic Tumor Microenvironment with Renal Clearable pH Nanoindicators, $103,923; Iscla, Irene, American Heart Assoc Natl, Novel Approach for Study of Function-Structure Relationships of Channels Involved in Ischemia and Angiogenesis, $77,000; Jain, Raksha, Cystic Fibrosis Fdn, Adult Therapeutics Development Network Additional Research Coordinator Award, $97,000; Mahendroo, Mala, Washington Univ St. Louis/March of Dimes, Transdisciplinary Center, $4,356; McCulley, James, Research to Prevent Blindness, RPB Unrestricted Research Grant – 2015, $115,000; Morrison, Sean (Fellow R. Yue), Damon Runyon Cancer Res Fdn, Functional Analysis of Leptin Receptor Signaling in Hematopoietic Stem Cells and Perivascular Niche, $53,000; Olson, Eric (Fellow K. Baskin), American Heart Assoc SW, Regulation of Cardiac Function and Metabolism by MED13, $51,092; Sathe, Meghana, Cystic Fibrosis Fdn, Cystic Fibrosis Therapeutics Development Center, $67,368;

Scaglioni, Pier, American Cancer Society, Identification of Critical Components of the K-RAS Network in Lung Cancer, $180,000; Stowe, Ann, American Heart Assoc Natl, B Cells Mediate Endogenous Neurovascular Protection Following Stroke, $77,000; Veeram Reddy, Surendranath, American Heart Assoc SW, Novel Design Biodegradable Stent in Porcine Model of Aortic Coarctation, $69,365; Welch, Robert, Orthopaedic Trauma Assoc, The Ossabaw Pig as a Musculoskeletal Model for Type II Diabetes, $23,937; Yanagisawa, Hiromi, American Heart Assoc Natl, Role of Fibulin-7, New Member of Fibulin ECM Proteins, in Development and Disease, $80,000; Yu, Hongtao, Clayton Fdn for Research, Development of Next Generation Antimitotic Anticancer Drugs, $300,000.

Industry sponsored awards, dollar amounts not available

Anderson, Larry, Phase 3 Study Comparing Daratumumab, Lenalidomide, and Dexamethasone (DRd) vs. Lenalidomide and Dexamethasone (Rd) in Sbjs with Relapsed or Refractory Multiple Myeloma, Janssen Res & Dev; Bezprozvanny, Ilya, Evaluation of SERCA Modulators in AD Model, Celladon Corp; Carr, Bruce, Phase 3 Study of AG200-15 Transdermal Contraceptive Delivery System (TCDS), Parexel Intl; Courtney, Kevin, SPARTAN: Phase 3 Study of ARN-509 in Men with Non-Metastatic (M0) Castration-Resistant Prostate Cancer, Clinverse Inc; Danuser, Gaudenz, To Validate a CureMeta Biomarker for Metastatic Cancer, Curemeta Inc; Iannaccone, Susan, Phase 3 Extension Study of Ataluren (PTC124) in Pts with Nonsense Mutation Dystrophinopathy, PTC Therapeutics Inc; Iannaccone, Susan, Phase 3 Study of ISIS 396443 Admin Intrathecally in Pts with Infantile-onset Spinal Muscular Atrophy, INC Research; Jia, Xun, Comprehensive Evaluations of Delivered Dose Accuracy in Lung radiation therapy, Varian Medical Systems Inc;

Knudsen, Erik, Functional Determinants of Response to LY2835219, Eli Lilly & Company; Laetsch, Theodore, Phase I Trial of NECTAR (Nelarabine, Etoposide and Cyclophosphamide in T-ALL Relapse): Joint Study of TACL and POETIC, Children’s Hosp of Los Angeles; Lavery, Lawrence, Phase 4 Study of DermaPure in Pts with "Hard to Heal" Chronic Neuropathic Diabetic Foot Ulcers with Crossover Design for Standard Care Arm, TRx Wound Care; Lingvay, Ildiko, Sustain-5-Add on Basal Insulin, Novo Nordisk Inc; Lu, Weiguo, 4D Rapid-Arc Planning, Varian Medical Systems Inc; Novakovic, Roberta, Investigate Various Flow Models Using PSS System Sensors, Endophys Holding LLC;

Sawant, Amit, Comprehensive Four-Dimensional Motion-Adaptive Lung SBRT, Varian Medical Systems Inc; Saxena, Ramesh, Study of Voclosporin w/Placebo in Achieving Remission in Pts with Active Lupus Nephritis, Pharm-Olam Intl Ltd; Scherer, Philipp, Application of Modification RNA Therapeutics to Achieve, Astrazeneca Pharm LP; Slone, Tamra, Study of Asparec as IV Infusion in Children and Young Adults with ALL or LBL Following Hypersensitivity to Pegaspargase, Children’s Hosp Phila; Szmuk, Peter, Phase 4 Study of Diclofenac Potassium Oral Solution in Pediatric Sbjs (2-12 yrs) with Mild to Moderate Acute Pain, Depomed Inc; Van Buren, Peter, Study of Canagliflozin on Renal and Cardiovascular Outcomes in Sbjs with Type 2 Diabetes Mellitus and Diabetic Nephropathy – CREDENCE Trial, Quintiles Inc.